2025 Axiom Group General Meeting

The meeting was marked by a positive balance sheet, the announcement of the new AXIOM 2030 strategic plan, a growth dynamic with steadily rising product performance, a strengthening of our positions in France and a reinforced presence with the world’s leading players.

The year 2024 in review

2024 was a year of structuring and strong development for the Axiom Group. With consolidated sales of €50 million, it was a year of efficiency, with the structuring of the Group’s activities and teams following the acquisition of Choice. Earnings improved by €1.2 million compared with 2023.

«2024 was a year of development for Axiom, despite an unfavorable context in Asia. The year was also important in terms of discovering the Choice network of customers and partners, and securing them, a task carried out both in France and internationally. In France, on a like-for-like basis, the volume of gilts distributed is up 6%, proof of the genetic quality of our products».Guillaume Naveau, CEO, Axiom Group

AXIOM 2030 Strategic Plan

Driven by continuous growth, the Axiom Group is now one of the world leaders in swine genetics, thanks to a structured strategy involving the development of an international network of partners, sustained investment in R&D, diversification of activities and adaptation to the needs of the swine industry. In just five years, the Group has tripled in size to become one of the world’s Top 5.

«We are well aware that, over and above product quality, the world’s biggest players want to deal with the leaders, and our position today enables us to develop this network of long-term partners. [...] Through this strategic plan, our aim is to contribute to the profitability of the pork industry worldwide, with customer satisfaction as our sole yardstick.» Guillaume Naveau, CEO, Axiom Group

Major 2025 projects and highlights

Three priorities were detailed at the GM:

• Core business: A well-thought-out strategy for high-performance products.
  This area covered: line optimization following the acquisition of Choice, constantly evolving line performance and product quality, illustrated by numerous testimonials from breeders in France and abroad. 4 R&D themes were developed: digestive efficiency with the Digestop project, the use of artificial intelligence through 5 ongoing projects, both in-house and in partnership, sequencing with the FrenchSeq project in partnership with GD Biotech, and embryo cryopreservation.
  «We are continually producing innovations, both in the short and medium term. The aim of our genetic strategy is to have a real impact on the performance of our products, thanks to innovative and effective criteria, new technologies and methods.»Guillaume Lenoir, Genetics Director, Axiom Group
• Project France: Development driven by customer satisfaction. 2024 was a year of development:
  • Strengthening our sales team in France: 7 sales territories to be closer to customers and partners. Growing our business: a positive trend in sow population over the last 2 years despite a declining market.
  • The leading breeding stock production network in France: a network covering all French territories, with an export focus to serve our foreign customers and partners. The Axiom Group is looking for new breeders to support its development.
  • A dynamic of new products with the success of Imagene, Axiom’s new self-renewal offer launched at SPACE 2024. A new product will also be presented at SPACE 2025.
    «It’s been a pivotal year for us, a year of commercial development: strengthening our presence in France with F1 gilts and self-renewal, expanding our breeding stock production network and, last but not least, maintaining our novelty dynamic. The right balance between these 3 pillars is the key to our future success.»Clément Girres, France Director, Axiom Group
• International project: A stronger presence with the world’s leading players.
  Genetics and pig production markets are becoming increasingly concentrated. The Axiom Group is now one of the world’s Top 5. Thanks to a growing presence in all production basins, with the exception of North America, Axiom genetics are meeting with strong interest from the world’s leading producers.

Conclusion

The year 2024 marks a new stage for Axiom, driven by a strong dynamic of structuring and development. Genetic performance continues to improve, the result of a differentiating strategy based on innovative criteria and pioneering R&D projects. More than ever focused on the profitability of its partners, the company strives to offer products that are ever more efficient, precise and adaptable to market expectations. Finally, the acceleration of our international business confirms the growing interest shown by leaders in the swine industry in Axiom genetics - a guarantee of quality, reliability and long-term vision.

«We are committed to offering profitable genetics for everyone: profitable for Axiom, profitable for cooperatives and, above all, profitable for users and producers. Today, we have a real lever for excellence and efficiency to meet the expectations of the world’s biggest industry leaders.»Arnaud Degoulet, President, Axiom Group

«We have a very clear plan for 2030, the strategy is mapped out and the Axiom team is on board. We’ll continue to establish ourselves around the world, including in France, where we’re capable of gaining positions.» Guillaume Naveau, CEO, Axiom Group